Upregulation of SLC26A9 resulted in the development and progression of HER2-positive breast cancer via activating PI3 K/AKT signaling pathway-MedSci.cn - williamhill asia

Upregulation of SLC26A9 resulted in the development and progression of HER2-positive breast cancer via activating PI3 K/AKT signaling pathway

Ma, Z; Lu, C; Zhu, J; Cheng, X; Tuo, B; Liu, X; Li, T

BREAST, 2021; 56 (): S26

科室
- - 订阅+
  - 更多科室
工具
服务